# OnCo record haystack-oncology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/haystack-oncology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "haystack-oncology" ;
  schema:name "Haystack Oncology"@en ;
  schema:description "Haystack Oncology, now owned by Quest Diagnostics, makes a blood test that looks for tiny traces of tumour DNA after cancer surgery to tell whether any cancer is left behind or coming back."@en ;
  schema:url <https://onco.cc/companies/haystack-oncology/>, <https://haystackmrd.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://haystackmrd.com/>, <https://www.sec.gov/Archives/edgar/data/1022079/000102207924000041/dgx-20231231.htm>, <https://haystackmrd.com/fda-grants-breakthrough-device-designation-for-haystack-mrd-circulating-tumor-dna-test-from-quest-diagnostics/>, <https://haystackmrd.com/haystack-mrd-receives-new-york-state-approval/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/wes-wgs/> .
